Opportunity

Simpler Grants.gov #HT942526PRMRPRAA

Army Medical Research Advancement Grant Solicitation (FY26 PRMRP)

Buyer

Dept. of the Army -- USAMRAA

Posted

May 08, 2026

Respond By

July 30, 2026

Identifier

HT942526PRMRPRAA

NAICS

541715

This opportunity from the Dept. of the Army USAMRAA invites applications for the FY26 Peer Reviewed Medical Research Program Research Advancement Award. - Government Buyer: - Dept. of the Army - U.S. Army Medical Research Acquisition Activity (USAMRAA) - Managed by Congressionally Directed Medical Research Programs (CDMRP) - OEMs and Vendors: - No specific OEMs or vendors named; this is a grant for fundamental medical research - Products/Services Requested: - Medical Research Advancement Grant - Supports use-inspired basic research studies for diseases or conditions related to FY26 PRMRP topic areas - Applications must include preliminary data - Research may range from hypothesis testing to expansion of mature data - Approximately 14 awards available - Each award capped at $1.4 million - Maximum period of performance: 4 years - Unique or Notable Requirements: - Preliminary data submission required - Registration with SAM.gov, eBRAP.org, and Grants.gov mandatory - Eligibility is unrestricted: domestic and foreign, for-profit and nonprofit, public or private organizations - Total program funding: $19.6 million - Place of Performance: - USAMRAA federal office (contracting office)

Description

The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Research Advancement Award supports fundamental research studies that contribute to research, patient care, and quality of life for diseases or conditions related to congressionally directed FY26 PRMRP topic areas and strategic goals. Applications must include preliminary data and support use-inspired basic research to validate or further preliminary findings for short- and long-term impact. The program expects to fund approximately 14 awards with a total cost cap of $1.4 million per award and a maximum performance period of 4 years. Awards will be funded with FY26 funds, expiring on September 30, 2032, and awarded no later than September 30, 2027.

View original listing